一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (803k)  required ID / password
Article in Japanese

Case Report

Drug-induced lung injury due to niraparib: a case report

Toshiyuki Yonezawaa  Saori Miyaraa  Noriko Moritab  Akihiko Wakatsukib  Satoru Itoa 

aDepartment of Respiratory Medicine and Allergology, Aichi Medical University
bDepartment of Obstetrics and Gynecology, Aichi Medical University

ABSTRACT

An 80-year-old woman was treated with niraparib, a poly ADP-ribose polymerase (PARP) inhibitor for stage IIIc ovarian cancer after surgery and adjuvant chemotherapy. Five months after starting to take niraparib, she was admitted to our hospital due to ground-glass opacities on chest computed tomography (CT). We diagnosed drug-induced lung injury due to niraparib based on the increased lymphocytes in the bronchoalveolar lavage fluid and the clinical course. Her condition became worse after discontinuation of niraparib alone but was improved by corticosteroid therapy. Because PARP inhibitors have been widely used for various malignancies, we should keep in mind the possibility of drug-induced lung injury.

KEYWORDS

Niraparib  Poly ADP-ribose polymerase (PARP) inhibitor  Drug-induced lung injury  Drug lymphocyte stimulation test (DLST) 

Received 31 Jul 2023 / Accepted 25 Sep 2023

AJRS, 13(1): 28-32, 2024

Google Scholar